Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aurinia Pharm Ord (AUPH)

Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Aurinia Pharmaceuticals Soars After Earnings Beat, Strategic Overhaul: Retail Sentiment Turns Extremely Bullish

Aurinia plans to slash 45% of its entire workforce with an aim to save more than $40 million in annual operating expenses.

IWO : 306.89 (+0.34%)
AUPH : 8.34 (+10.90%)
IWM : 236.38 (-0.35%)
Aurinia: Q3 Earnings Snapshot

Aurinia: Q3 Earnings Snapshot

AUPH : 8.34 (+10.90%)
Aurinia: Q2 Earnings Snapshot

Aurinia: Q2 Earnings Snapshot

AUPH : 8.34 (+10.90%)
Why Aurinia Pharmaceuticals Stock Is Slumping Today

The biotech's premium valuation doesn't seem to be sitting well with investors.

AUPH : 8.34 (+10.90%)
Why Aurinia Pharmaceuticals Stock Is Marching Higher Friday

The biotech's board is exploring strategic alternatives to boost shareholder value.

NVS : 107.08 (+0.25%)
BMY : 54.71 (-1.03%)
AUPH : 8.34 (+10.90%)
S&P Futures Climb Ahead of Key U.S. Inflation Data

September S&P 500 futures (ESU23) are trending up +0.33% this morning as market participants awaited a reading on the Federal Reserve’s preferred inflation gauge.

ESU23 : 4,491.72s (-0.32%)
WFC : 69.82 (-3.66%)
JPM : 236.38 (-4.32%)
BAC : 44.77 (-1.41%)
OXY : 51.21 (-0.35%)
MU : 113.41 (+1.41%)
ENGI.P.DX : 15.240 (+1.50%)
NKE : 75.92 (+0.80%)
ACCD : 3.56 (+4.40%)
AUPH : 8.34 (+10.90%)
CCL : 23.68 (-2.27%)
NVDA : 148.88 (+2.25%)
MKT Capital Issues Statement Regarding Aurinia’s Disappointing First Quarter 2023 Financial Results

MKT Capital Ltd. (together with its affiliates, “MKT Capital” or “we”), a significant shareholder of Aurinia Pharmaceuticals, Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) with beneficial...

AUPH : 8.34 (+10.90%)
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for first quarter ended March 31, 2023. Amounts are expressed in U.S. dollars.

AUPH : 8.34 (+10.90%)
ISS Recommends Aurinia Shareholders Vote Against the Company’s Named Executive Officers’ Compensation

MKT Capital Ltd. (together with its affiliates, “MKT Capital” or “we”), a significant shareholder of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) with beneficial...

AUPH : 8.34 (+10.90%)
Aurinia Pharmaceuticals Announces NICE Recommendation of LUPKYNIS® (Voclosporin) For Adults with Active Lupus Nephritis

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the National Institute for Health and Care Excellence (NICE) has recommended LUPKYNIS ® (voclosporin) as an option...

AUPH : 8.34 (+10.90%)

Barchart Exclusives

1 Energy Dividend Stock That Just Hiked Its Cash Flow Forecast
Analysts are optimistic about this dividend-paying energy company, which raised its cash flow forecast after surging LNG demand pushed it past Q3 expectations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar